EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia

EULAR/ACR risk stratification criteria have been developed for people with arthralgia in secondary care who are considered at risk for RA. They can be applied in the absence or presence of imaging data and have been developed to define homogeneous risk groups for future prevention trials.

Authors

Institutions

Publication Details

Journal
Annals of the Rheumatic Diseases
Published
2025-05-09
DOI
https://doi.org/10.1016/j.ard.2025.01.021
Citations
17
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
28.36
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia

Andrew P. Cope, H.W. van Steenbergen, Stefano Alivernini, Bernard Combe et al.
17 citations
Annals of the Rheumatic Diseases
Rheumatoid Arthritis Research and Therapies
28.36
article

EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia

Andrew P. Cope, H.W. van Steenbergen, Stefano Alivernini, Bernard Combe, Kevin D. Deane, Jeffrey A. Sparks, Marie Falahee, Kulveer Mankia, Paul Studenic, Annette H M van der Helm–van Mil, Bertha Maat, Johan Bäcklund, Arnd Kleyer, Pascal H P de Jong, Diane Lacaille, György Nagy, Stanley Cohen, Karim Raza, Ilfita Sahbudin, Liam J. O’Neil, Alexandre Rocha Sepriano, Bryant R. England, Dirkjan van Schaardenburg, Ewout W. Steyerberg, Elise van Mulligen, Frank Doornkamp, José António Pereira da Silva, L. De Smet, Cătălin Codreanu, R. Landewé, Linda Rodamaker, Elisabeth Wethington
article en
17 citations

Abstract

EULAR/ACR risk stratification criteria have been developed for people with arthralgia in secondary care who are considered at risk for RA. They can be applied in the absence or presence of imaging data and have been developed to define homogeneous risk groups for future prevention trials.

Annals of the Rheumatic DiseasesVol. 84(9)
Brigham and Women's Hospital (US), Harvard University (US), King's College London (GB), Université de Montpellier (FR), Swedish Rheumatism Association (SE), Leiden University Medical Center (NL), Hospitais da Universidade de Coimbra (PT), National Jewish Health (US), Reade (NL), Research Canada (CA), NIHR Leeds Musculoskeletal Biomedical Research Unit (GB), Arthritis and Rheumatism Associates (US), European League Against Rheumatism (CH), Arthritis Research Centre of Canada (CA), VA Nebraska Western Iowa Health Care System (US), Risk Engineering (Bulgaria) (BG), University of Manitoba (CA), University of Colorado Anschutz Medical Campus (US), University of Birmingham (GB), The University of Texas Southwestern Medical Center (US), Erasmus University Rotterdam (NL), University of Colorado Denver (US)
Zero hunger
Openalex Percentile: Top 0%
Rheumatoid Arthritis Research and Therapies
28.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.